|
Matrix Assigns Part of its Astrix Purchase Rights to Parent Company
Matrix Laboratories Appoints S. Srinivasan as Managing Director and CEO, Promotes B. Hari Babu, Ph.D., to Chief Operating Officer
Notice regarding payment of calls-in-arrears
Matrix and Aspen agree to divest Joint Ventures
Matrix Laboratories has posted a Net Sales of Rs.9386.33 Mio on a stand alone basis reflecting an increase of 25.3% over the previous financial year. Out of the total revenues, APIs (active pharmaceutical ingredients) accounted for 77% and FDFs (finished dosage forms) accounted for the balance.
|
